首页> Cancer letters> Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells

Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells

导出原文传递

翻译打印收藏纠错

第一作者： Goebel, Andy

作者： Goebel, Andy ^[1] ; Thiele, Stefanie ; Browne, Andrew J. ; Rauner, Martina ; Zinna, Valentina M. ; Hofbauer, Lorenz C. ; Rachner, Tilman D.

作者单位： Tech Univ Dresden, Dept Med 3, Div Endocrinol Diabet & Bone Dis, D-01062 Dresden, Germany ^[1]

关键词 Breast cancer Statins Zoledronic acid Mevalonate pathway Apoptosis Rho-GTPases

发布时间 2017-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Cancer letters

2016年375卷1期

162-171页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览2

点击下载本期目录封面

Cancer letters

2016年375卷1期

162-171页

检索历史清除

Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells

Cancer letters

相似文献

同项目论文

Cancer letters

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells

Cancer letters

相似文献

同项目论文

Cancer letters

相关期刊

检索历史清除